Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Manali Petrochemicals Ltd

MANALIPETC
NSE
53.43
0.58%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Manali Petrochemicals Ltd

MANALIPETC
NSE
53.43
0.58%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
919Cr
Close
Close Price
53.43
Industry
Industry
Petrochem - Polymers
PE
Price To Earnings
8.22
PS
Price To Sales
0.96
Revenue
Revenue
960Cr
Rev Gr TTM
Revenue Growth TTM
4.01%
PAT Gr TTM
PAT Growth TTM
464.58%
Peer Comparison
How does MANALIPETC stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MANALIPETC
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
334301270205256240230196230235248247
Growth YoY
Revenue Growth YoY%
-19.4-7.1-5.5-13.9-23.2-20.2-14.7-4.2-10.1-2.47.725.9
Expenses
ExpensesCr
327294255200239220226183209212228233
Operating Profit
Operating ProfitCr
68155172141321232014
OPM
OPM%
1.82.55.42.56.88.61.76.59.19.78.25.7
Other Income
Other IncomeCr
57981664581271
Interest Expense
Interest ExpenseCr
222233233333
Depreciation
DepreciationCr
766677777889
PBT
PBTCr
261558181816202172
Tax
TaxCr
324275025634
PAT
PATCr
041131130511141868
Growth YoY
PAT Growth YoY%
-100.6-88.7-7.0-6.7388.9216.8-98.279.3731.510.18,975.01,198.5
NPM
NPM%
-0.11.44.01.40.55.40.12.74.76.17.327.7
EPS
EPS
0.00.20.60.20.10.80.00.30.60.81.14.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
5796327488108031,0241,6721,1771,032897960
Growth
Revenue Growth%
9.218.38.3-0.927.663.2-29.6-12.3-13.17.0
Expenses
ExpensesCr
5125726517127337241,1431,103988839882
Operating Profit
Operating ProfitCr
676097997030152974455878
OPM
OPM%
11.59.513.012.28.729.431.66.34.36.58.1
Other Income
Other IncomeCr
11133285-71128242195
Interest Expense
Interest ExpenseCr
32326599101013
Depreciation
DepreciationCr
61091114212023252731
PBT
PBTCr
69618811454268511703342129
Tax
TaxCr
2122303786712919141318
PAT
PATCr
4840587747201381511929112
Growth
PAT Growth%
-17.546.432.3-39.1331.389.4-86.7-62.152.6281.2
NPM
NPM%
8.36.37.79.45.819.622.84.31.93.311.6
EPS
EPS
2.82.34.24.52.711.722.23.01.11.76.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
8686868686868686868686
Reserves
ReservesCr
1962443063693955949449589761,0081,056
Current Liabilities
Current LiabilitiesCr
212210139169126169185147163209217
Non Current Liabilities
Non Current LiabilitiesCr
5162530534375838499113
Total Liabilities
Total LiabilitiesCr
4995565566546608921,2901,2741,3081,4031,472
Current Assets
Current AssetsCr
355273250342310550908674701692735
Non Current Assets
Non Current AssetsCr
144283306312350342382600607711736
Total Assets
Total AssetsCr
4995565566546608921,2901,2741,3081,4031,472

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-6875813872193739275-19
Investing Cash Flow
Investing Cash FlowCr
-7-124-22-17-21-15-13-267-82-155
Financing Cash Flow
Financing Cash FlowCr
-116-17-2-29-28-26-64-70
Net Cash Flow
Net Cash FlowCr
-24-3119-638176334-239-14-174
Free Cash Flow
Free Cash FlowCr
-6875813872193739275-19
CFO To PAT
CFO To PAT%
-12.4220.8100.417.6187.3108.697.9181.3388.6-64.8
CFO To EBITDA
CFO To EBITDA%
-8.9145.659.913.7124.972.770.5123.7167.2-32.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4326875764361741,0201,8641,034967966
Price To Earnings
Price To Earnings
9.318.210.05.73.75.14.920.450.233.0
Price To Sales
Price To Sales
0.81.10.80.50.21.01.10.90.91.1
Price To Book
Price To Book
1.52.21.51.00.41.51.81.00.90.9
EV To EBITDA
EV To EBITDA
6.311.46.04.12.02.52.48.812.713.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
31.629.333.634.530.046.245.428.730.835.4
OPM
OPM%
11.59.513.012.28.729.431.66.34.36.5
NPM
NPM%
8.36.37.79.45.819.622.84.31.93.3
ROCE
ROCE%
25.117.821.923.711.939.349.67.54.04.3
ROE
ROE%
17.012.014.816.89.729.637.04.81.82.7
ROA
ROA%
9.67.110.411.77.122.629.54.01.52.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Manali Petrochemicals Limited (MPL), headquartered in Chennai, India, is a leading integrated petrochemical manufacturer and a part of the USD 2+ billion Singapore-based AM International group. MPL specializes in propylene glycol (PG), polyols, and a range of specialty chemicals. It is **India’s only fully integrated polyol producer**, with backward integration from propylene to polyol and derivative products. The company aims to transition toward a more sustainable and innovation-driven model, leveraging global acquisitions, R&D, and ESG-aligned strategies. --- ### **Strategic Direction (Current Focus: Nov 2025)** As of Q3 2025, Manali Petrochemicals is undergoing a strategic shift from a commodity-focused business to a **balanced commodity-specialty portfolio** with a target revenue mix of **80% commodities and 20% specialty chemicals**. Growth is being driven by: - Acquisition-led expansion - Localization of production in India and Asia - Sustainability and green innovation - Market diversification across Asia-Pacific, Europe, and the Middle East --- ### **Key Developments (Latest Updates: Apr–Jun 2025)** #### **1. Appointment of Mr. Sundar Saimani (Jun 2025)** - Dr. Sundar Saimani, a PhD in Chemistry with post-doctoral research and over a decade of senior management experience from Dow Chemicals, has joined the leadership team. - Brings deep expertise in **polyurethane systems, business development, and market expansion** in automotive, construction, and industrial sectors. - Expected to strengthen MPL’s R&D and market positioning in high-growth polyurethane applications. #### **2. Expansion into Asia-Pacific via Local Manufacturing (Apr 2025)** - New manufacturing plant in Oragadam, Tamil Nadu (India), will serve as a **strategic base** for expansion into the Asia-Pacific region. - Plant to be developed under **PennWhite India Private Limited**, a wholly owned subsidiary of PennWhite Limited (UK), which operates under MPL. - Aims to localize production of **high-specification foam control agents** (defoamers), reducing import dependency and improving lead times. #### **3. PennWhite India Manufacturing Facility (Apr 2025)** - PennWhite India’s new facility will mirror the **quality standards** of its UK counterpart and pursue **equivalent international certifications**. - Indian customers will be able to source **FoamDoctor®-grade defoamers domestically**, with **no change in performance or application**. - Expected to increase **technical support availability, product customization**, and service efficiency for Indian clients. #### **4. Acquisition & Integration Strategy** - **2022 Acquisition**: MPL, through its subsidiary AMCHEM Singapore, acquired **Penn Globe Limited (PGL)** for GBP 24.98 million, bringing **Penn-White Limited** (antifoam leader) and **PennWhite Print Solutions Limited** under its umbrella. - **2024 Incorporation**: **PennWhite India Private Limited** established in Chennai to serve Indian and South Asian markets. - **Feb 2025**: PennWhite India acquired a **domestic Indian defoamer business**, including intellectual property (IP), portfolios, and customer contracts — the first step in a long-term India investment plan targeting the **fertilizer and food industries**. --- ### **Business Segments & Product Portfolio** #### **Core Commodity Products (80% of revenue target)** | Product | Capacity / Position | Key Applications | |--------|----------------------|------------------| | **Propylene Glycol (PG)** | ~100,000 tons/year (Sole Indian producer) | Pharmaceuticals, food & beverage, cosmetics, antifreeze | | **Propylene Oxide (PO)** | India’s first & largest producer | Feedstock for PG, polyols, glycol ethers | | **Polyols** | Integrated PO-PG-Polyols chain (100,000 T/month) | PU foams for insulation, furniture, automotive | #### **Specialty & Niche Segments (20% target, high-margin)** | Subsidiary | Product | Key Industries | |----------|--------|----------------| | **PennWhite (UK & India)** | FoamDoctor® antifoams, silicone emulsions, release agents, lubricants | Food processing, wastewater, oil & gas, coatings, printing | | **Notedome (UK & Germany)** | Neuthane® polyurethane cast elastomers | Mining, defense, agriculture, subsea, energy | | **In-house (MPL)** | Bio-based PU, green polyols, fire-resistant PIR | Sustainable manufacturing, construction, insulation | --- ### **Growth & Expansion Initiatives** #### **1. India-Focused Manufacturing** - **Project**: Greenfield defoamer plant in Oragadam, Tamil Nadu (via PennWhite India). - **Investment**: Internally funded; part of a broader localization strategy. - **Objective**: Capture 10% of India’s **35,000-ton foam control chemistry market**, particularly the premium 17,500-ton segment currently 50% import-dependent. - **Synergy**: Access to local PO, polyols, and renewable energy from parent co. #### **2. Polyol & Propylene Glycol Expansions** | Project | Detail | |-------|--------| | **New PG Plant** | 32,000 MTPA capacity, ₹94 crores investment, 20.7% IRR | | **Polyester Polyol Plant (Phase II)** | Under evaluation, to serve construction and elastomers | | **Greenfield Polyol Expansion (West India)** | 30,000 MTPA, ₹130+ crores, 30% IRR, 5-year payback | #### **3. Sustainability & Green Innovation** - **Econic Technology MoU**: Deployment of CO₂-based catalysts to produce **sustainable polyols**. - **Solar Energy Integration**: Planned solar panels to reduce OpEx and carbon footprint. - **Bio-based R&D**: Supplying 100% bio-based crosslinkers to a UK customer; trialing 75% bio-based MDI prepolymer. - **Low-carbon Formulations**: Water-based, vegetable oil-based defoamers with biodegradability and low toxicity. --- ### **Market Position & Competitive Landscape** | Segment | Position | |--------|---------| | **India – PG & PO** | Sole domestic producer, market leader | | **India – Polyols** | Only fully integrated PU manufacturer | | **Global – Defoamers (PennWhite)** | Operates in 50+ countries, branded under **FoamDoctor®** | | **Global – Cast Elastomers (Notedome)** | 45+ years, serves 40+ industries, $1.4B market, 5.3% CAGR | | **India – Antifoam Market** | Targeting premium segment; limited local competition; global players (Dow, Henkel) avoid overlap | **Competitive Advantages:** - Vertical integration (from propylene to final products) - Lower forex risk due to local manufacturing - Strong R&D and formulation expertise - Focus on **value-added, high-performance solutions** over price - Sustainability-driven customer partnerships --- ### **Financial & Operational Highlights** - **Revenue Mix (Target)**: 80% commodities, 20% specialty chemicals - **Historical Revenue (FY22)**: ₹1,690 crores | **EBITDA**: ₹547 crores - **Capex Strategy**: Brownfield and greenfield expansions funded via accruals and debt (e.g., 50:50 debt-equity for new PG plant) - **Margin Drivers**: Operational efficiency, portfolio restructuring, cost leadership in energy and raw materials - **Propylene Dependency**: Major input sourced from crude oil; benefits from declining Brent prices - **Rupee Risk Mitigation**: Local production for Asian markets reduces USD/INR exposure --- ### **Leadership & Governance** - **MD**: Mr. Muthukrishnan Ravi – Key driver of international acquisitions and export strategy. - **CEO – PennWhite Ltd**: Mr. Tobias Tasche (appointed Jul 2023) – Former Shell executive, 25 years in specialty chemicals and supply chain. - **New Leadership (Jun 2025)**: Dr. Sundar Saimani – Strengthening technical leadership in polyurethanes and PU systems. --- ### **Geographic & Market Strategy** | Region | Strategy | |--------|---------| | **India** | Localization of defoamer and specialty chem production; expand PG and PU captive consumption | | **Asia-Pacific** | Manufacturing hub in Tamil Nadu to serve SEA, Japan, Australia | | **Europe & UK** | Direct sales growth, strategic distribution (e.g., with KRAHN UK for silicone oils), rebranding and integration | | **Middle East & Africa (MENA)** | Strengthen distribution via trade shows and partnerships | | **Nordics & Spain** | New distribution agreements underway; expansion in energy and cable sectors | --- ### **Challenges** - **Propylene Supply Constraints**: High domestic prices and limited availability affecting polyol utilization. - **Import Competition**: Uncontrolled imports in PU sector; anti-dumping duties only partially effective. - **Supplier Concentration**: 46% raw material purchases from Dow (as of Dec 2022). - **Margin Pressure**: From rising input costs, although partially offset by adaptive pricing and efficiency measures.